Literature DB >> 17303088

Transient fear-induced alterations in evoked release of norepinephrine and GABA in amygdala slices.

Xianling Liu1, György Lonart, Larry D Sanford.   

Abstract

Presentation of a tonal cue that previously had been associated with a fearful experience (footshock) produces alterations in arousal and sleep that occur after the fearful cue is no longer presented. To begin investigating neurochemical mechanisms that may underlie the effects of fearful cue presentation, we measured release of [(3)H]-norepinephrine ([(3)H]-NE]) and [(14)C]-gamma-amino-butyric acid ([(14)C]-GABA) from brain regions known to regulate arousal states and REM sleep. Depolarization-evoked release of [(3)H]-NE from amygdalar slices of mice, which were trained to recognize a tone as a fearful cue, was suppressed at 2-3 h after exposure of animals to the fearful cue, but recovered after 4-5 h. Interestingly, depolarization-evoked release of [(14)C]-GABA was significantly increased in the amygdala, and also showed a tendency for enhancement in the hippocampus, NPO, and DRN at 2-3 h after cue presentation. The changes in [(14)C]-GABA release were also transient; 4-5 h after cue presentation no significant differences were detected between samples derived from experimental groups which experienced fearful or neutral cues. The similar time course of fearful cue-induced changes in neurotransmitter release and changes in arousal and REM sleep suggests that alterations in amygdalar neurotransmission may be involved in the changes in arousal and sleep that occur after fear.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303088      PMCID: PMC1868561          DOI: 10.1016/j.brainres.2007.01.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  51 in total

Review 1.  The amygdala: vigilance and emotion.

Authors:  M Davis; P J Whalen
Journal:  Mol Psychiatry       Date:  2001-01       Impact factor: 15.992

2.  Inactivity produces increases in neurotransmitter release and synapse size.

Authors:  V N Murthy; T Schikorski; C F Stevens; Y Zhu
Journal:  Neuron       Date:  2001-11-20       Impact factor: 17.173

3.  GABAergic regulation of the central nucleus of the amygdala: implications for sleep control.

Authors:  Larry D Sanford; Brian Parris; Xiangdong Tang
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

4.  [Role of basolateral amygdaloid nuclei in sleep and wakeful state regulation].

Authors:  G Q Zhu; M K Zhong; J X Zhang; L Z Zhao; D P Ke; M Wang; L Shi
Journal:  Sheng Li Xue Bao       Date:  1998-12

5.  Monoamines and sleep: microdialysis findings in pons and amygdala.

Authors:  M N Shouse; R J Staba; S F Saquib; P R Farber
Journal:  Brain Res       Date:  2000-03-31       Impact factor: 3.252

6.  Prolactin microinjections into the amygdalar central nucleus lead to decreased NREM sleep.

Authors:  L D Sanford; P Nassar; R J Ross; J Schulkin; A R Morrison
Journal:  Sleep Res Online       Date:  1998

7.  Influence of shock training and explicit fear-conditioned cues on sleep architecture in mice: strain comparison.

Authors:  Larry D Sanford; Xiangdong Tang; Richard J Ross; Adrian R Morrison
Journal:  Behav Genet       Date:  2003-01       Impact factor: 2.805

8.  Reduction of extracellular GABA in the mouse amygdala during and following confrontation with a conditioned fear stimulus.

Authors:  Oliver Stork; Feng Yun Ji; Kunihiko Obata
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

9.  Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity.

Authors:  Larry D Sanford; Linghui Yang; Xianling Liu; Xiangdong Tang
Journal:  Brain Res       Date:  2006-03-20       Impact factor: 3.252

10.  In vivo microdialysis measures of extracellular norepinephrine in the rat amygdala during sleep-wakefulness.

Authors:  Sung Pa Park
Journal:  J Korean Med Sci       Date:  2002-06       Impact factor: 2.153

View more
  3 in total

1.  Functional development of the ovarian noradrenergic innervation.

Authors:  Manuel Ricu; Alfonso Paredes; Monika Greiner; Sergio R Ojeda; Hernan E Lara
Journal:  Endocrinology       Date:  2007-10-18       Impact factor: 4.736

2.  Norepinephrine homogeneously inhibits alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate- (AMPAR-) mediated currents in all layers of the temporal cortex of the rat.

Authors:  Lu Dinh; Tram Nguyen; Humberto Salgado; Marco Atzori
Journal:  Neurochem Res       Date:  2009-04-09       Impact factor: 3.996

Review 3.  Noradrenergic Modulation of Fear Conditioning and Extinction.

Authors:  Thomas F Giustino; Stephen Maren
Journal:  Front Behav Neurosci       Date:  2018-03-13       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.